Securities Class Action
Securities fraud litigation history and active cases
In Litigation
1
Settlement
0
Closed
0
Total Settlement
$0
Eiger BioPharmaceuticals, Inc. (EIGR) Class Action Lawsuit (November 2022)
In Litigation3:22cv6985 • November 8, 2022
Class Period Start
March 10, 2021
Class Period End
October 4, 2022
PSLRA Deadline
January 9, 2023
Case Allegations
10b5
Statutes of Repose
Mar 10, 2024
Country
United States
Court
Federal Court
Docket History
Apr 10, 2023
Voluntary Dismissal (opens in a new tab)
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Feb 3, 2023
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Nov 8, 2022
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in Eiger BioPharmaceuticals, Inc..